Opioid-Related Critical Care Resource Use in US Children's Hospitals

Jason M Kane1,2, Jeffrey D Colvin3, Allison H Bartlett4

  • 1Sections of Pediatric Critical Care and jasonk@uchicago.edu.

Pediatrics
|March 7, 2018
PubMed

Insights

Pediatric opioid ingestions are increasing hospitalizations and critical care use. This study found a doubling of pediatric intensive care unit (PICU) admissions for opioid ingestions from 2004-2015, highlighting an urgent need for prevention.

Area of Science:

  • Pediatric Critical Care Medicine
  • Toxicology
  • Public Health

Background:

  • The US is experiencing a rapid rise in pediatric opioid-related hospitalizations.
  • The impact of this trend on pediatric critical care resource utilization remains largely unexamined.

Purpose of the Study:

  • To analyze trends in pediatric hospitalizations for opioid ingestions across US children's hospitals.
  • To specifically assess the effect of these ingestions on the demand for pediatric critical care services.

Main Methods:

  • A retrospective cohort study utilized data from the Pediatric Health Information System (2004-2015).
  • Hospitalizations for opioid ingestions were identified, and pediatric intensive care unit (PICU) admission, naloxone use, vasopressor, and ventilation support were analyzed.
  • Poisson regression was employed to determine trends in PICU admission rates.

Main Results:

  • 3,647 opioid-related hospitalizations occurred across 31 hospitals, with 42.9% requiring PICU admission.
  • The number of PICU admissions for opioid ingestions doubled between 2004 and 2015.
  • PICU admission rates rose significantly, and a substantial proportion of these children required mechanical ventilation (37.0%) or vasopressors (20.3%).

Conclusions:

  • The opioid crisis significantly affects children, evidenced by rising hospitalization and PICU admission rates for opioid ingestions.
  • Existing strategies to curb adult opioid use have not reduced pediatric opioid ingestions.
  • Enhanced interventions are crucial to prevent childhood exposure to opioids.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...